SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    S. Pierre, A. Chevallier, F. Teixeira-Clerc, A. Ambolet-Camoit, L.-C. Bui, A.-S. Bats, J.-C. Fournet, P. Fernandez-Salguero, M. Aggerbeck, S. Lotersztajn, R. Barouki, X. Coumoul, Aryl Hydrocarbon Receptor-Dependent Induction of Liver Fibrosis by Dioxin, Toxicological Sciences, 2014, 137, 1, 114

    CrossRef

  2. 2
    Conrado M. Fernández Rodriguez, Maria Luisa Gutierrez Garcia, Impacto del tratamiento antiviral en la historia natural del virus de la hepatitis C, Gastroenterología y Hepatología, 2014,

    CrossRef

  3. 3
    Lei Yu, Chihiro Morishima, George N. Ioannou, Dietary Cholesterol Intake Is Associated With Progression of Liver Disease in Patients With Chronic Hepatitis C: Analysis of the Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial, Clinical Gastroenterology and Hepatology, 2013, 11, 12, 1661

    CrossRef

  4. 4
    Behzad Hajarizadeh, Jason Grebely, Gregory J. Dore, Epidemiology and natural history of HCV infection, Nature Reviews Gastroenterology & Hepatology, 2013, 10, 9, 553

    CrossRef

  5. 5
    Chung-Oui Hong, Chae Hong Rhee, Nam-Hee Won, Hee-Don Choi, Kwang-Won Lee, Protective effect of 70% ethanolic extract of Lindera obtusiloba Blume on tert-butyl hydroperoxide-induced oxidative hepatotoxicity in rats, Food and Chemical Toxicology, 2013, 53, 214

    CrossRef

  6. 6
    L. Dirven, N. B. Klarenbeek, M. Broek, J. H. L. M. Groenendael, P. B. J. Sonnaville, P. J. S. M Kerstens, T. W. J. Huizinga, B. A. C. Dijkmans, W. F. Lems, C. F. Allaart, Risk of alanine transferase (ALT) elevation in patients with rheumatoid arthritis treated with methotrexate in a DAS-steered strategy, Clinical Rheumatology, 2013, 32, 5, 585

    CrossRef

  7. 7
    Mohammad K. Mohammad, Diana Avila, Jingwen Zhang, Shirish Barve, Gavin Arteel, Craig McClain, Swati Joshi-Barve, Acrolein cytotoxicity in hepatocytes involves endoplasmic reticulum stress, mitochondrial dysfunction and oxidative stress, Toxicology and Applied Pharmacology, 2012, 265, 1, 73

    CrossRef

  8. 8
    Jacqueline G. O’Leary, Gary L. Davis, HCV and Chemotherapy: Does Infection Change Management?, Current Hepatitis Reports, 2012, 11, 1, 34

    CrossRef

  9. 9
    Junpei Soeda, Maelle Morgan, Chad McKee, Angelina Mouralidarane, ChingI Lin, Tania Roskams, Jude A. Oben, Nicotine induces fibrogenic changes in human liver via nicotinic acetylcholine receptors expressed on hepatic stellate cells, Biochemical and Biophysical Research Communications, 2012, 417, 1, 17

    CrossRef

  10. 10
    Christophe Corpechot, Farid Gaouar, Yves Chrétien, Catherine Johanet, Olivier Chazouillères, Raoul Poupon, Smoking as an independent risk factor of liver fibrosis in primary biliary cirrhosis, Journal of Hepatology, 2012, 56, 1, 218

    CrossRef

  11. 11
    Li Zhao, Limin Xu, Yinyan Lai, Caiyan Che, Yanxia Zhou, Temporal changes of smoking status and motivation in Chinese patients with hepatitis B: relationship with anxiety and depression, Journal of Clinical Nursing, 2012, 21, 15-16
  12. 12
    Kai-Chung Yang, Yi-Shin Huang, Chin-Lin Perng, Han-Chieh Lin, Shou-Dong Lee, Polymorphism of N-acetyltransferase 2 Gene and the Susceptibility to Alcoholic Liver Cirrhosis: Interaction With Smoking, Alcoholism: Clinical and Experimental Research, 2011, 35, 7
  13. 13
    Claudia O. Zein, Aynur Unalp, Ryan Colvin, Yao-Chang Liu, Arthur J. McCullough, Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease, Journal of Hepatology, 2011, 54, 4, 753

    CrossRef

  14. You have free access to this content14
    R. Huttunen, T. Heikkinen, J. Syrjänen, Smoking and the outcome of infection, Journal of Internal Medicine, 2011, 269, 3
  15. 15
    D. Yamini, B. Basseri, G. M. Chee, A. Arakelyan, P. Enayati, T. T. Tran, F. Poordad, Tobacco and other factors have a negative impact on quality of life in hepatitis C patients, Journal of Viral Hepatitis, 2011, 18, 10
  16. 16
    Nobuyoshi Fukushima, Ryoko Kuromatsu, Teruko Arinaga-Hino, Eiji Ando, Akio Takata, Shuji Sumie, Masahito Nakano, Takumi Kawaguchi, Tatsuya Ide, Takuji Torimura, Michio Sata, Adipocytokine involvement in hepatocellular carcinoma after sustained response to interferon for chronic hepatitis C, Hepatology Research, 2010, 40, 9
  17. You have free access to this content17
    Lorenzo Azzalini, Elisabet Ferrer, Leandra N. Ramalho, Montserrat Moreno, Marlene Domínguez, Jordi Colmenero, Víctor I. Peinado, Joan A. Barberà, Vicente Arroyo, Pere Ginès, Joan Caballería, Ramón Bataller, Cigarette smoking exacerbates nonalcoholic fatty liver disease in obese rats, Hepatology, 2010, 51, 5
  18. You have free access to this content18
    Claudia O. Zein, Clearing the smoke in chronic liver diseases, Hepatology, 2010, 51, 5
  19. 19
    José L. Alonso-Martínez, Francisco J. Anniccherico-Sánchez, Miren Urbieta-Echezarreta, Jose L. Garcia-Sanchotena, Fernando Olaz-Preciado, Hemodynamic effects of chronic smoking in liver cirrhosis: a role for adrenomedullin, European Journal of Gastroenterology & Hepatology, 2010, 22, 5, 513

    CrossRef

  20. 20
    Robert L. Carithers, Craig J. Mcclain, Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 2010,

    CrossRef

  21. 21
    Jacqueline G. O’Leary, Gary L. Davis, Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 2010,

    CrossRef

  22. 22
    Swati Joshi-Barve, Kiranmayi Amancherla, Madhuvanti Patil, Aruni Bhatnagar, Stephanie Mathews, Leila Gobejishvili, Matthew Cave, Craig McClain, Shirish Barve, Acrolein, a ubiquitous pollutant and lipid hydroperoxide product, inhibits antiviral activity of interferon-α: relevance to hepatitis C, Free Radical Biology and Medicine, 2009, 47, 1, 47

    CrossRef

  23. 23
    C. Zani, F. Donato, M. Chiesa, C. Baiguera, U. Gelatti, L. Covolo, M.G. Antonini, P. Nasta, F. Gatti, G. Orizio, M. Puoti, Alcohol and coffee drinking and smoking habit among subjects with HCV infection, Digestive and Liver Disease, 2009, 41, 8, 599

    CrossRef

  24. 24
    Ariane Mallat, Sophie Lotersztajn, Cigarette smoke exposure: A novel cofactor of NAFLD progression?, Journal of Hepatology, 2009, 51, 3, 430

    CrossRef

  25. 25
    C. Hezode, A. Mallat, Comorbidité et hépatotoxicité du tabac et des substances récréatives, Gastroentérologie Clinique et Biologique, 2009, 33, 12, 1131

    CrossRef

  26. 26
    Shannon M. Bailey, Sudheer K. Mantena, Telisha Millender-Swain, Yavuz Cakir, Nirag C. Jhala, David Chhieng, Kent E. Pinkerton, Scott W. Ballinger, Ethanol and tobacco smoke increase hepatic steatosis and hypoxia in the hypercholesterolemic apoE−/− mouse: Implications for a “multihit” hypothesis of fatty liver disease, Free Radical Biology and Medicine, 2009, 46, 7, 928

    CrossRef

  27. 27
    Florence Trivin, Eveline Boucher, Elodie Vauléon, Isabelle Cumin, Elisabeth Le Prisé, Odile Audrain, Jean-Luc Raoul, Management of Esophageal Carcinoma Associated with Cirrhosis: A Retrospective Case-Control Analysis, Journal of Oncology, 2009, 2009, 1

    CrossRef

  28. 28
    T. J. S. Cross, A. Quaglia, S. Hughes, D. Joshi, P. M. Harrison, The impact of hepatic steatosis on the natural history of chronic hepatitis C infection, Journal of Viral Hepatitis, 2009, 16, 7
  29. 29
    Laurent Michel, Jean-Philippe Lang, Christophe Hézode, Psychiatrie, VIH et hépatite C, 2009,

    CrossRef

  30. 30
    J. L. Narciso-Schiavon, L. L. Schiavon, R. J. Carvalho-Filho, F. C. F. Freire, J. R. Cardoso, J. O. Bordin, A. E. B. Silva, M. L. G. Ferraz, Anti-hepatitis C virus-positive blood donors: are women any different?, Transfusion Medicine, 2008, 18, 3
  31. 31
    Patrice Couzigou, Juliette Foucher, Laurent Castera, Victor De Ledinghen, Comment gérer les comorbidités en hépatologie ? Vers une médecine plus globale, La Presse Médicale, 2008, 37, 9, 1274

    CrossRef

  32. 32
    Sharif B. Missiha, Mario Ostrowski, E. Jenny Heathcote, Disease Progression in Chronic Hepatitis C: Modifiable and Nonmodifiable Factors, Gastroenterology, 2008, 134, 6, 1699

    CrossRef

  33. 33
    M. Underner, S. Hadjadj, M. Beauchant, F. Bridoux, F. Debiais, J.-C. Meurice, Effets du tabagisme sur la thyroïde, le tube digestif, le rein et l’os, Revue des Maladies Respiratoires, 2008, 25, 10, 1261

    CrossRef

  34. 34
    Ariane Mallat, Christophe Hezode, Sophie Lotersztajn, Environmental factors as disease accelerators during chronic hepatitis C, Journal of Hepatology, 2008, 48, 4, 657

    CrossRef

  35. 35
    Eva A. Operskalski, Wendy J. Mack, Howard D. Strickler, Audrey L. French, Michael Augenbraun, Phyllis C. Tien, Maria C. Villacres, LaShonda Y. Spencer, Marina DeGiacomo, Andrea Kovacs, Factors associated with hepatitis C viremia in a large cohort of HIV-infected and -uninfected women, Journal of Clinical Virology, 2008, 41, 4, 255

    CrossRef

  36. 36
    Curtis L. Cooper, Obstacles to Successful HCV Treatment in Substance Addicted Patients, Journal of Addictive Diseases, 2008, 27, 2, 61

    CrossRef

  37. 37
    Debbie Rybak, Michael B. Fallon, Michael J. Krowka, Robert S. Brown, Jenna Reinen, Linda Stadheim, Dorothy Faulk, Carrie Nielsen, Nadine Al-Naamani, Kari Roberts, Steven Zacks, Ted Perry, James Trotter, Steven M. Kawut, Risk factors and impact of chronic obstructive pulmonary disease in candidates for liver transplantation, Liver Transplantation, 2008, 14, 9
  38. 38
    P. Couzigou, Comment, en Afrique, gérer les comorbidités en hépatologie?, Journal Africain d’Hépato-Gastroentérologie, 2007, 1, 1, 63

    CrossRef

  39. 39
    Hui-I Hsieh, Pau-Chung Chen, Ruey-Hong Wong, Jung-Der Wang, Pei-Ming Yang, Tsun-Jen Cheng, Effect of the CYP2E1 genotype on vinyl chloride monomer-induced liver fibrosis among polyvinyl chloride workers, Toxicology, 2007, 239, 1-2, 34

    CrossRef

  40. 40
    Fernando Agüero, Montserrat Laguno, Asuncion Moreno, Antonio Rimola, José M Miró, Management of end-stage liver disease in HIV-infected patients, Current Opinion in HIV and AIDS, 2007, 2, 6, 474

    CrossRef

  41. 41
    Hidir Pekmez, Ilter Kus, Neriman Colakoglu, Murat Ogeturk, Huseyin Ozyurt, Asli Ozdem Turkoglu, Mustafa Sarsilmaz, The protective effects of caffeic acid phenethyl ester (CAPE) against liver damage induced by cigarette smoke inhalation in rats, Cell Biochemistry and Function, 2007, 25, 4
  42. 42
    Robert A. Levine, Schuyler O. Sanderson, Robert Ploutz–Snyder, Frank Murray, Elaine Kay, John Hegarty, Niamh Nolan, Dermot Kelleher, George Mcdonald, J. Conor O’Keane, John Crowe, Assessment of Fibrosis Progression in Untreated Irish Women With Chronic Hepatitis C Contracted From Immunoglobulin Anti-D, Clinical Gastroenterology and Hepatology, 2006, 4, 10, 1271

    CrossRef

  43. 43
    Dominique Guyader, Fabrice Lainé, Conduite à tenir devant une cytolyse chronique, EMC - Hépatologie, 2006, 1, 1, 1

    CrossRef

  44. 44
    Robert J. Fontana, Arun J. Sanyal, Savant Mehta, Michael C. Doherty, Brent A. Neuschwander-Tetri, Gregory T. Everson, Jeffrey A. Kahn, Peter F. Malet, Muhammad Y. Sheikh, Raymond T. Chung, Marc G. Ghany, David R. Gretch, Portal Hypertensive Gastropathy in Chronic Hepatitis C Patients with Bridging Fibrosis and Compensated Cirrhosis: Results from the HALT-C Trial, The American Journal of Gastroenterology, 2006, 101, 5, 983

    CrossRef

  45. 45
    Gioacchino Leandro, Alessandra Mangia, Jason Hui, Paolo Fabris, Laura Rubbia–Brandt, Guido Colloredo, Luigi E. Adinolfi, Tarik Asselah, Julie R. Jonsson, Antonina Smedile, Norah Terrault, Valerio Pazienza, Maria Teresa Giordani, Emiliano Giostra, Aurelio Sonzogni, Giuseppe Ruggiero, Patrick Marcellin, Elizabeth E. Powell, Jacob George, Francesco Negro, Relationship Between Steatosis, Inflammation, and Fibrosis in Chronic Hepatitis C: A Meta-Analysis of Individual Patient Data, Gastroenterology, 2006, 130, 6, 1636

    CrossRef

  46. 46
    Anouk Dev, Keyur Patel, Andrew Conrad, Lawrence M. Blatt, John G. McHutchison, Relationship of Smoking and Fibrosis in Patients With Chronic Hepatitis C, Clinical Gastroenterology and Hepatology, 2006, 4, 6, 797

    CrossRef

  47. 47
    Paul Sanchez, Ellen Heck, Christine Rivera, Angela Sanchez, H Dwight Cavanagh, Risk Factors for Infectious Disease in Corneal Transplant Screening, Eye & Contact Lens: Science & Clinical Practice, 2006, 32, 3, 124

    CrossRef

  48. 48
    Claudia O. Zein, Kristi Beatty, Anthony B. Post, Laurie Logan, Sara Debanne, Arthur J. McCullough, Smoking and increased severity of hepatic fibrosis in primary biliary cirrhosis: A cross validated retrospective assessment, Hepatology, 2006, 44, 6
  49. 49
    F Donato, U Gelatti, R M Limina, G Fattovich, Southern Europe as an example of interaction between various environmental factors: a systematic review of the epidemiologic evidence, Oncogene, 2006, 25, 27, 3756

    CrossRef

  50. 50
    Ramón Bataller, Time to ban smoking in patients with chronic liver diseases, Hepatology, 2006, 44, 6
  51. 51
    Christophe Hézode, Françoise Roudot-Thoraval, Son Nguyen, Pascale Grenard, Boris Julien, Elie-Serge Zafrani, Jean-Michel Pawlostky, Daniel Dhumeaux, Sophie Lotersztajn, Ariane Mallat, Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C, Hepatology, 2005, 42, 1
  52. 52
    Sharon J. Hutchinson, Sheila M. Bird, David J. Goldberg, Influence of Alcohol on the Progression of Hepatitis C Virus Infection: A Meta-analysis, Clinical Gastroenterology and Hepatology, 2005, 3, 11, 1150

    CrossRef

  53. 53
    Michiko Yamada, F.Lennie Wong, Saeko Fujiwara, Yoshimi Tatsukawa, Gen Suzuki, Smoking and Alcohol Habits as Risk Factors for Benign Digestive Diseases in a Japanese Population: The Radiation Effects Research Foundation Adult Health Study, Digestion, 2005, 71, 4, 231

    CrossRef

  54. 54
    Norihiko Kubo, Norihiro Furusyo, Hisashi Nakashima, Kenichiro Kashiwagi, Jun Hayashi, Strenuous physical labor is important as a cause of elevated alanine aminotransferase levels in Japanese patients with chronic hepatitis C viremia, European Journal of Epidemiology, 2005, 20, 3, 251

    CrossRef

  55. 55
    Francesco Negro, Hepatitis C virus and liver steatosis: when fat is not beautiful, Journal of Hepatology, 2004, 40, 3, 533

    CrossRef

  56. 56
    Manuel Rubio Caballero, Carmen Rubio Rivas, Ramón Egido García, Antonio Nogués Biau, Hepatitis crónica por el virus de la hepatitis C en pacientes infectados por el virus de la inmunodeficiencia humana. Estudio de 55 casos con biopsia hepática, Medicina Clínica, 2004, 123, 12, 441

    CrossRef

  57. 57
    Takashi Hashimoto, Masashi Yoneda, Tadahito Shimada, Mieko Kurosawa, Akira Terano, Intraportal nicotine infusion in rats decreases hepatic blood flow through endothelin-1 and both endothelin A and endothelin B receptors, Toxicology and Applied Pharmacology, 2004, 196, 1, 1

    CrossRef

  58. 58
    Vincent Di Martino, Pascal Lebray, Robert P. Myers, Emmanuelle Pannier, Valérie Paradis, Frédéric Charlotte, Joseph Moussalli, Dominique Thabut, Catherine Buffet, Thierry Poynard, Progression of liver fibrosis in women infected with hepatitis C: Long-term benefit of estrogen exposure, Hepatology, 2004, 40, 6
  59. 59
    T. E. S. Delahooke, What is the nature of the problem?, Journal of Viral Hepatitis, 2004, 11,
  60. 60
    Gavin Arteel, Luis Marsano, Christian Mendez, Frederick Bentley, Craig J McClain, Advances in alcoholic liver disease, Best Practice & Research Clinical Gastroenterology, 2003, 17, 4, 625

    CrossRef

  61. 61
    Michelle M. Lipman, Scott J. Cotler, Antiviral therapy for hepatitis C, Current Treatment Options in Gastroenterology, 2003, 6, 6, 445

    CrossRef

  62. 62
    Timothy R. Morgan, David Brenner, James Everhart, Samuel W. French, Michael W. Fried, David R. Gretch, Margaret James Koziel, Craig J. McClain, Marion G. Peters, Steven A. Weinman, Diane L. Lucas, Hepatitis C and Alcohol: Fundamental and Translational Research Directions, Alcoholism: Clinical and Experimental Research, 2003, 27, 4
  63. 63
    Timothy R. Morgan, David Brenner, James Everhart, Samuel W. French, Michael W. Fried, David R. Gretch, Margaret James Koziel, Craig J. McClain, Marion G. Peters, Steven A. Weinman, Diane L. Lucas, Hepatitis C and Alcohol: Fundamental and Translational Research Directions, Alcoholism: Clinical & Experimental Research, 2003, 27, 4, 726

    CrossRef

  64. 64
    Marian Fireman, Hepatitis C Treatment and Substance Use Disorders, Psychiatric Annals, 2003, 33, 6, 402

    CrossRef

  65. 65
    Patricia E. Molina, Craig McClain, Dominique Valla, David Guidot, Anna Mae Diehl, Charles H. Lang, Manuela Neuman, Molecular Pathology and Clinical Aspects of Alcohol-Induced Tissue Injury, Alcoholism: Clinical & Experimental Research, 2002, 26, 1, 120

    CrossRef

  66. 66
    Patricia E. Molina, Craig McClain, Dominique Valla, David Guidot, Anna Mae Diehl, Charles H. Lang, Manuela Neuman, Molecular Pathology and Clinical Aspects of Alcohol-Induced Tissue Injury, Alcoholism: Clinical and Experimental Research, 2002, 26, 1
  67. 67
    Leonard B. Seeff, Natural history of chronic hepatitis C, Hepatology, 2002, 36, S1
  68. 68
    P. Cacoub, Y. Benhamou, Place des interférons dans le traitement des infections par les virusde l'hépatite B et de l'hépatite C, La Revue de Médecine Interne, 2002, 23, 459S

    CrossRef

  69. 69
    Laurent Castera, Natural History of Chronic HCV Infection and Non-Invasive Assessment of Hepatic Fibrosis,